IOVANCE BIOTHERAPEUTICS, INC. Inventory, Noncurrent
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) had Inventory, Noncurrent of $6.20 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2026-08-06
- 2026-06-30: Inventory, Noncurrent $6.20M.
- 2026-03-31: Inventory, Noncurrent $8.00M.
- 2025-12-31: Inventory, Noncurrent $7.90M.
- 2025-09-30: Inventory, Noncurrent $8.80M.
| Period end | Inventory, Noncurrent |
|---|---|
| 2026-06-30 | $6.20M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $8.00M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $7.90M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $8.80M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $9.80M 10-Q · filed 2025-08-07 |
| 2024-12-31 | $0.00 10-K · filed 2026-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |